Late marginal ulcer perforation after Roux-en-Y Gastric bypass - A case report with two-step management.

Bariatric surgery Case report Perforated marginal ulcer Two-step procedure

Journal

International journal of surgery case reports
ISSN: 2210-2612
Titre abrégé: Int J Surg Case Rep
Pays: Netherlands
ID NLM: 101529872

Informations de publication

Date de publication:
30 Apr 2024
Historique:
received: 01 04 2024
revised: 25 04 2024
accepted: 26 04 2024
medline: 8 5 2024
pubmed: 8 5 2024
entrez: 7 5 2024
Statut: aheadofprint

Résumé

Marginal ulcers are an acid-related complication of laparoscopic Roux-en-Y gastric bypass. Few cases of acute perforation have been described, and there are few reports on viable surgical management. This case report demonstrates a two-step surgical procedure for treating a perforated late marginal ulcer in a patient with sepsis. A 39-year-old smoker presented to the emergency department six years after undergoing a Roux-en-Y gastric bypass. Diagnostic findings revealed ascites and changes in intestinal calibre, indicating the need for surgery. Intraoperatively, a perforated marginal ulcer covered by the liver was observed. Given the extent of the perforation and the patient's increased instability, discontinuity resection was performed. After stabilisation and improvement in the nutritional status, the gastrojejunostomy was restored nine weeks later. Treatment of Marginal ulcers is controversial, with no clear guidelines. However, severe complications require endoscopic or surgical treatment. The literature considers three main surgical treatment options for perforated marginal ulcers: surgical repair, surgical anastomotic revision, and gastric bypass reversal. Complicated situations, significant intraoperative findings, and unstable patients require tailored approaches. A two-step procedure with discontinuity resection for damage control surgery, patient stabilisation, and improvement of nutritional status, followed by elective continuity restoration with a new gastrojejunostomy, is considered feasible in critically ill patients.

Identifiants

pubmed: 38714069
pii: S2210-2612(24)00501-7
doi: 10.1016/j.ijscr.2024.109720
pii:
doi:

Types de publication

Case Reports

Langues

eng

Pagination

109720

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest statement The authors declare no conflict of interest.

Auteurs

Nina Pfeifer (N)

Department of General, Visceral, Endocrine and Transplant Surgery & Bariatric Surgery Center of Eastern Switzerland, Cantonal Hospital St. Gallen, St. Gallen, Switzerland. Electronic address: nina-pfeifer@gmx.ch.

Thomas Steffen (T)

Department of General, Visceral, Endocrine and Transplant Surgery & Bariatric Surgery Center of Eastern Switzerland, Cantonal Hospital St. Gallen, St. Gallen, Switzerland. Electronic address: thomas.steffen@kssg.ch.

Larissa Clea Vines (LC)

Oncology (solid tumors) Janssen-Cilag AG Schweiz/Zug, Switzerland. Electronic address: lvines@its.jnj.com.

Patrick Folie (P)

Department of General, Visceral, Endocrine and Transplant Surgery & Bariatric Surgery Center of Eastern Switzerland, Cantonal Hospital St. Gallen, St. Gallen, Switzerland. Electronic address: patrick.folie@kssg.ch.

Classifications MeSH